Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Minassian

Showing results (251-260 of 324) with videos related to

Pageof 33
Sort By:
Nature Clinical Practice. Neurology|February 8, 2008
Typical progression of myoclonic epilepsy of the Lafora type: a case reportPasquale Striano, Federico Zara, Julie Turnbull, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 8, 1998
Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndromeT M DeLorey, A Handforth, S G Anagnostaras, et al.
Cell Metabolism|May 14, 2013
Hyperphosphorylation of glucosyl C6 carbons and altered structure of glycogen in the neurodegenerative epilepsy Lafora diseaseFelix Nitschke, Peixiang Wang, Peter Schmieder, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2007
Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivoVincent S Tagliabracci, Julie Turnbull, Wei Wang, et al.
The American Journal of Pathology|February 1, 1989
Cellular localization of simian immunodeficiency virus in lymphoid tissues. I. Immunohistochemistry and electron microscopyD J Ringler, M S Wyand, D G Walsh, et al.
The Journal of Biological Chemistry|December 25, 2019
Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa<sub>v</sub>1.7Robert A Neff, Mack Flinspach, Alan Gibbs, et al.
American Journal of Human Genetics|November 5, 1997
Lafora progressive myoclonus epilepsy: narrowing the chromosome 6q24 locus by recombinations and homozygositiesJ Sainz, B A Minassian, J M Serratosa, et al.
Acta Neuropathologica|February 27, 2024
Myofiber-type-dependent 'boulder' or 'multitudinous pebble' formations across distinct amylopectinosesSharmistha Mitra, Baozhi Chen, John M Shelton, et al.
EMBO Molecular Medicine|May 25, 2017
Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora diseaseFelix Nitschke, Mitchell A Sullivan, Peixiang Wang, et al.
Epilepsia|August 31, 2019
Both gain-of-function and loss-of-function de novo CACNA1A mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox-Gastaut syndromeXiao Jiang, Praveen K Raju, Nazzareno D'Avanzo, et al.
Pageof 33

Showing results (251-260 of 324) with videos related to

Sort By:
Pageof 33
Nature Clinical Practice. Neurology|February 8, 2008
Typical progression of myoclonic epilepsy of the Lafora type: a case reportPasquale Striano, Federico Zara, Julie Turnbull, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 8, 1998
Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndromeT M DeLorey, A Handforth, S G Anagnostaras, et al.
Cell Metabolism|May 14, 2013
Hyperphosphorylation of glucosyl C6 carbons and altered structure of glycogen in the neurodegenerative epilepsy Lafora diseaseFelix Nitschke, Peixiang Wang, Peter Schmieder, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2007
Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivoVincent S Tagliabracci, Julie Turnbull, Wei Wang, et al.
The American Journal of Pathology|February 1, 1989
Cellular localization of simian immunodeficiency virus in lymphoid tissues. I. Immunohistochemistry and electron microscopyD J Ringler, M S Wyand, D G Walsh, et al.
The Journal of Biological Chemistry|December 25, 2019
Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa<sub>v</sub>1.7Robert A Neff, Mack Flinspach, Alan Gibbs, et al.
American Journal of Human Genetics|November 5, 1997
Lafora progressive myoclonus epilepsy: narrowing the chromosome 6q24 locus by recombinations and homozygositiesJ Sainz, B A Minassian, J M Serratosa, et al.
Acta Neuropathologica|February 27, 2024
Myofiber-type-dependent 'boulder' or 'multitudinous pebble' formations across distinct amylopectinosesSharmistha Mitra, Baozhi Chen, John M Shelton, et al.
EMBO Molecular Medicine|May 25, 2017
Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora diseaseFelix Nitschke, Mitchell A Sullivan, Peixiang Wang, et al.
Epilepsia|August 31, 2019
Both gain-of-function and loss-of-function de novo CACNA1A mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox-Gastaut syndromeXiao Jiang, Praveen K Raju, Nazzareno D'Avanzo, et al.
Pageof 33